GREAT LAKES ADVISORS, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1078013
CHICAGO, IL
Position in CRL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$459,476
+$109,991 QoQ
Shares Held
2,026
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#313
of 564 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GREAT LAKES ADVISORS, LLC holds $122,300,093 across 9 Diagnostics & Research names. CRL ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
214,974 | $107,779,362 | |
| 2 | LH |
Labcorp Holdings Inc.
|
20,883 | $5,847,240 | |
| 3 | VCYT |
Veracyte, Inc.
|
65,579 | $3,851,454 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,991 | $2,101,021 | |
| 5 | DHR |
Danaher Corp /De/
|
7,498 | $1,428,218 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,026 | $459,476 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,234 | $296,742 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,455 | $281,135 |
All Filings in CRL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $459,476 | 2,026 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $349,485 | 2,026 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $411,726 | 2,064 | Shares | Sole | 2026-02-12 | |
| 2024-12-31 | $350,186 | 1,897 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $379,955 | 1,929 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $883,336 | 4,276 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,177,548 | 4,346 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,109,898 | 4,695 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,159,613 | 5,917 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $468,647 | 2,229 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,713,909 | 23,357 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $431,659 | 1,981 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $418,593 | 2,127 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $13,034,196 | 60,916 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $18,428,517 | 64,896 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $31,988,998 | 84,901 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $35,920,860 | 87,045 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $32,967,640 | 89,121 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $26,426,989 | 91,181 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $21,769,052 | 87,125 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $30,052,405 | 132,711 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $18,973,638 | 108,825 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $12,990,669 | 102,929 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||